MGRX · Mangoceuticals, Inc.
$0.40
-0.01 (-1.72%)
At close · Aug 31
Going-concern doubt
— flagged Aug 13, 2026
Substantial doubt about the company's ability to continue as a going concern.
“These factors raise substantial doubt about the ability of the Company to continue as a going concern. Unless management is able to obtain additional financing, it is unlikely that the Company will be able to meet its funding requirements during the 12 months from the date of issuance of this filing.”View the 10-Q filed Aug 13, 2026
Market Cap
$8.67M
Shares
21.57M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 8-K | 2026-08-21 | 2026-08-19 | |
| 10-Q | 2026-08-13 | 2026-06-30 | |
| 8-K | 2026-08-04 | — | |
| 8-K | 2026-07-30 | 2026-07-28 | |
| 8-K | 2026-07-02 | 2026-06-29 | |
| 10-Q | 2026-05-19 | 2026-03-31 | |
| 10-K | 2026-04-01 | 2025-12-31 | |
| 8-K | 2026-03-17 | 2026-03-16 | |
| 8-K | 2026-02-23 | — | |
| 8-K | 2026-02-19 | — | |
| 8-K | 2026-02-06 | 2026-02-04 | |
| 8-K | 2025-12-19 | 2025-12-18 | |
| 8-K | 2025-12-19 | 2025-12-17 | |
| 8-K | 2025-12-10 | 2025-12-04 | |
| 10-Q | 2025-11-14 | 2025-09-30 | |
| 10-Q/A | 2025-11-14 | 2025-06-30 | |
| 8-K | 2025-11-14 | 2025-11-13 | |
| 8-K | 2025-11-13 | — | |
| 8-K | 2025-10-29 | 2025-09-15 | |
| 8-K | 2025-09-12 | 2025-09-09 | |
| 8-K | 2025-09-02 | 2025-08-26 | |
| 10-Q | 2025-08-14 | 2025-06-30 | |
| 8-K | 2025-08-04 | 2025-07-30 | |
| 8-K | 2025-07-23 | 2025-06-10 | |
| 8-K | 2025-07-10 | 2025-07-03 | |
| 8-K | 2025-07-03 | 2025-07-01 | |
| 8-K | 2025-06-10 | 2025-06-02 | |
| 8-K | 2025-05-30 | 2025-05-15 | |
| 8-K | 2025-05-23 | 2025-05-22 | |
| 10-Q | 2025-05-15 | 2025-03-31 | |
| 8-K | 2025-05-06 | 2025-04-28 | |
| 8-K | 2025-04-25 | 2025-04-24 | |
| 8-K | 2025-04-17 | 2025-04-11 | |
| 8-K | 2025-04-11 | 2025-04-10 | |
| 8-K | 2025-04-08 | 2025-03-28 | |
| 8-K | 2025-04-02 | 2025-03-28 | |
| 8-K | 2025-03-28 | 2025-03-25 | |
| 8-K | 2025-03-25 | 2025-03-20 | |
| 10-K | 2025-03-20 | 2024-12-31 | |
| 8-K | 2025-03-19 | 2025-03-17 | |
| 8-K | 2025-02-19 | 2025-02-14 | |
| DEF 14A | 2025-02-18 | — | |
| 8-K | 2025-02-12 | 2025-02-07 | |
| 8-K | 2025-02-12 | — | |
| 8-K | 2025-02-07 | 2025-02-03 | |
| 8-K | 2025-01-31 | 2025-01-27 | |
| 8-K | 2025-01-21 | 2025-01-15 | |
| 8-K | 2025-01-15 | 2025-01-09 | |
| 8-K | 2025-01-08 | 2024-12-31 | |
| 8-K | 2024-12-26 | 2024-12-18 |
Showing 1–50 of 94 filings
Key facts
CIK
1938046
CUSIP
56270V205
13F (30d)
15 filings
15 filers
Visit website
Investor relations